Korro Bio
KRRO
100 hedge funds and large institutions have $751M invested in Korro Bio in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.
414% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 7
102% more capital invested
Capital invested by funds: $373M → $751M (+$378M)
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
41% more funds holding
Funds holding: 71 → 100 (+29)
0.11% more ownership
Funds ownership: 1.15% → 1.26% (+0.11%)
71% less call options, than puts
Call options by funds: $2.11M | Put options by funds: $7.32M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$26.1M |
| 2 |
Morgan Stanley
New York
|
+$10.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$9.4M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.77M |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$2.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MS
Mizuho Securities
Tokyo,
Japan
|
-$9.05M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$2.46M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.65M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$787K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$615K |
KRRO Hedge Fund Activity: Q4 2020 in Review
100 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2020, worth a combined $751M — up 102% from $373M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new KRRO positions and 7 closed out — a net gain of 29 holders — while 27 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $26.1M. The largest seller was Mizuho Securities, exiting entirely with an estimated $9.05M sold.
- 100 institutional investors held Korro Bio (KRRO) as of Q4 2020, up from 71 in Q3 2020.
- Funds reported $751M of Korro Bio stock for Q4 2020, up 102% quarter-over-quarter.
- 36 funds opened new Korro Bio positions in Q4 2020 and 7 closed out, a net change of +29 holders.
- The largest Korro Bio buyer in Q4 2020 was BlackRock, an estimated $26.1M added.
- The largest Korro Bio seller in Q4 2020 was Mizuho Securities, an estimated $9.05M sold.
Based on aggregated 13F filings for Q4 2020.